Long-Term Monitoring & Surveillance

Managing CAH and adrenal rest tumors is a lifelong journey. Because these tumors are benign and often do not cause symptoms you can feel, consistent monitoring—also called surveillance—is your best defense against long-term complications ^[1][2].

Monitoring for Males (TART)

Regular screening is an important part of care for boys and men with CAH.

• When to Start: Routine scrotal ultrasound is often initiated around the start of puberty for males with classic CAH ^[3][1].
• Earlier Screening: Doctors may recommend starting ultrasounds earlier in childhood for boys with more severe forms of CAH, such as the salt-wasting type, or if hormone levels have been difficult to control ^[4][1].
• Frequency: Once you reach adulthood, many specialized centers recommend an annual ultrasound, but the exact interval should be individualized depending on your age, prior TART findings, tumor size, and specialist guidance ^[3][2]. This allows your doctor to track any changes in the tumor’s size, appearance, or blood flow over time ^[5].
• What is Tracked: Beyond tumor size, the ultrasound also measures testicular volume, which is an important indicator of overall testicular health ^[2][4].
• What if a scan is abnormal? If a new, enlarging, unilateral, or increasingly vascular lesion is found, this requires a clear escalation pathway: prompt review by endocrinology and urology, comparison with prior imaging, appropriate tumor-marker blood tests, and specialist decisions about further imaging or surgery to ensure it is not cancer.

Monitoring for Females (OART)

The approach for girls and women is very different because OARTs are exceptionally rare and difficult to see on standard scans ^[6][7].

• No Routine Scans: Currently, routine pelvic imaging (ultrasound or MRI) is not recommended for women who do not have symptoms ^[3][6]. Because these tumors are so rare and standard scans often miss them, “screening” usually leads to more confusion than clarity ^[6].
• Symptom-Based Evaluation: Instead of regular scans, monitoring for OART relies on tracking your symptoms and hormone levels ^[3]. Evaluation with MRI or specialized ultrasound is only triggered if you experience:
  • Persistent virilization (like a deepening voice or excessive hair growth) despite treatment ^[7][8].
  • Ongoing amenorrhea (lack of periods) or severe infertility ^[7][9].
  • Unexplained spikes in adrenal hormones that do not respond to medication adjustments ^[7][9].

The Role of Lab Work in Surveillance

An ultrasound only tells part of the story. To understand if your treatment is working, scans must be paired with regular blood tests, often called biochemical monitoring ^[3].

• Key Markers: Your doctor will look at levels of ACTH, 17-OHP, androstenedione, and renin, alongside blood pressure, growth/weight, electrolytes, and bone health ^[10][11].
• Longitudinal Tracking: Rather than looking at a single lab result, your team looks at how these levels change over months and years ^[10]. High levels of ACTH are a critical risk factor for the growth of adrenal rest tumors, but they are just one part of an individualized assessment ^[4][12]. Never try to force ACTH or 17-OHP to “normal” with excessive steroid dosing on your own.
• Timing Matters: The correct time to have your blood drawn depends heavily on the specific glucocorticoid you take, your dose, and your clinic’s protocol. Follow your endocrinologist’s exact instructions regarding medication timing before a blood draw. And remember, never withhold a dose if you are acutely ill or having an emergency.

Navigating ‘Scan Anxiety’

Living with a chronic condition that requires lifelong monitoring can take an emotional toll. It is common to experience scan anxiety—a feeling of dread or worry in the days leading up to an appointment.

Research shows that anxiety is more prevalent in youth and adults with CAH compared to those without the condition ^[13][14]. This is a natural response to the psychological weight of ongoing medical surveillance. Many patients find it helpful to:

• Schedule all tests on the same day to minimize trips to the clinic (if that helps reduce stress).
• Ask their doctor for a concrete results plan: exactly who will call with the results, how many days it will take, and what the next steps will be if the report shows an indeterminate finding.
• Connect with CAH support groups to share experiences with others who understand the burden of long-term monitoring.

Remember, the goal of these check-ups is not to “find something wrong,” but to provide the data needed to keep your treatment as effective and as gentle as possible ^[15].

Glossary of Terms

• 17-OHP (17-hydroxyprogesterone): A hormone precursor that builds up in the blood when the adrenal glands cannot make cortisol; used as a key marker to monitor CAH control.
• ACTH (Adrenocorticotropic Hormone): A hormone from the brain that signals the adrenal glands to produce cortisol.
• Azoospermia: The absence of measurable sperm in the semen.
• Fibrosis: Thickening and scarring of tissue.
• Mediastinum testis: A network of fibrous tissue in the back of the testicle where blood vessels and sperm tubes enter and exit.
• Rete testis: A network of small tubules in the testicle that carries sperm from the seminiferous tubules to the efferent ducts.
• TESE / IVF / ICSI: Advanced reproductive techniques used to retrieve sperm directly from the testicle (TESE) and use it to fertilize an egg in a lab (IVF/ICSI).